Global Navigation
Office of The Attorney General
The State of New Jersey Office of The Attorney General (Dept. of Law & Public Safety) The State of New Jersey NJ Home Services A to Z Departments/Agencies OAG Frequently Asked Questions
Services A to Z Departments/Agencies OAG Frequently Asked Questions
OAG Home
OAG Contact
spacer
Back to News Releases
OAG Home Attorney General's Biography
Attorney General's Biography
spacer spacer spacer
 
spacer spacer spacer
spacer spacer spacer
For Immediate Release:
For Further Information:
November 15, 2012 

Office of The Attorney General
- Jeffrey S. Chiesa, Attorney General
Division of Law
- Christopher S. Porrino, Director
Media Inquiries-
Lee Moore
609-292-4791


Citizen Inquiries-

609-984-5828
spacer
spacer spacer spacer
spacer
State to Receive More Than $2.5 Million Under Settlement Resolving Allegations That GlaxoSmithKline Made Misleading Claims About Drug  
spacer
spacer spacer spacer
spacer
spacer
spacer spacer spacer
spacer
TRENTON – Attorney General Jeffrey S. Chiesa announced today that New Jersey will receive approximately $2.54 million as a result of its participation in a multi-state settlement with GlaxoSmithKline (GSK) that resolves allegations the company misrepresented the cardiovascular safety of its diabetes drug Avandia.

Under terms of the settlement, GSK has agreed to pay a total of $90 million to 38 states, including New Jersey, to resolve allegations it violated consumer protection laws by misrepresenting both the risk of heart attack associated with Avandia, as well as the safety of using Avandia alone, and in conjunction with other diabetes drugs.

In addition to the monetary terms, the settlement includes a number of conditions designed to prevent future misleading or deceptive communications related to Avandia, as well as any other GSK products marketed for glycemic control for patients with Type 2 diabetes.

“This settlement is important to protecting New Jersey consumers because it calls for the use of only clear, objective, scientifically-supported information in the promotion of GlaxoSmithKline’s Type 2 diabetes products,” said Attorney General Chiesa. “In addition, the settlement contains certain accountability and transparency provisions that will ensure that health care providers have timely access to the results of  observational studies and clinical trials focused on these drugs.” 

A Consent Judgment memorializing the settlement was filed today in New Jersey Superior Court. The Consent Judgment provides that GSK:

  • Will not make comparative safety claims unsupported by substantial evidence or substantial clinical experience;

  • Will not present favorable information previously thought of as valid but rendered invalid by contrary, and more credible, recent information;

  • Will not promote investigational drugs;

  • Will not misuse statistics or otherwise misrepresent the nature, applicability, or significance of clinical trials.

The settlement requires that GSK  post summaries of all GSK-sponsored observational studies or meta-analyses conducted by the company that are designed to inform the effective, safe, and/or appropriate use of any GSK diabetes product.

It also requires that summaries of all GSK–sponsored clinical trials of diabetes products must be posted within eight months of the trial’s primary completion date.
 
Under the settlement, GSK must also register and post all GSK-sponsored clinical trials as required by Public Law No. 110-85, and must comply with the ICMJE Uniform Requirements for Manuscripts submitted to Biomedical Journals.

Deputy Attorney General Alina Wells, assigned to the Division of Law’s Consumer Fraud Prosecution Section, handled the Avandia matter on behalf of the State.

The Avandia investigation was led by the Attorneys General of Oregon and Illinois, with an Executive Committee consisting of the Attorneys General of Arizona, Florida, Maryland, Pennsylvania, Tennessee, and Texas. Along with New Jersey, other participants in the settlement include: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Idaho, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, Rhode Island, South Dakota, Vermont, Washington, and Wisconsin.

###

spacer
spacer spacer spacer
spacer
 
 
Contact OAG About OAG
OAG News OAG Frequently Asked Questions
OAG Library Employment
OAG Grants Proposed Rules
OAG History OAG Services A-Z
OAG Agencies / Programs / Units
Other News Pages Otras Noticias en Español Division of NJ State Police Division of Law News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Gaming Enforcement News
NJ State Police News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Elections News Division of Gaming Enforcement News Office of Government Integrity News

free PDF plugin

NJ State Police News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Elections News Division of Gaming Enforcement News Office of Government Integrity News
   
Contact Us | Privacy Notice | Legal Statement | Accessibility Statement
NJ Home Logo
Departmental: OAG Home | Contact OAG | About OAG | OAG News | OAG FAQs
Statewide: NJ Home | Services A to Z | Departments/Agencies | FAQs
Copyright © State of New Jersey
This page is maintained by OAG Communications. Comments/Questions: email or call 609-292-4925
OAG Home OAG Home NJ State Police News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Elections News Division of Gaming Enforcement News Office of Government Integrity News Click to Enlarge Image Click to Enlarge Image Click to Enlarge Graphic Click to enlarge chart Click to enlarge map